There is considerable interest in the role of the TRK family of neurot
rophin receptors in regulating the survival, growth and differentiatio
n of normal and neoplastic nerve cells. Indeed, there is increasing ev
idence that TRK genes play an important role in the biology and clinic
al behavior of neuroblastomas, tumors of the peripheral nervous system
. Evidence from several independent studies suggests that high express
ion of TrkA is an indicator of favorable outcome, and there is an inve
rse correlation between TrkA expression and N-myc amplification. In ad
dition, some primary neuroblastomas differentiate in vitro in the pres
ence of NGF but die in its absence. We have evidence that coexpression
of full-length TrkB and BDNF is associated with N-myc amplification a
nd may represent an autocrine survival pathway. Conversely, truncated
TrkB is expressed predominantly in differentiated tumors. Finally, Trk
C is expressed in favorable neuroblastomas, essentially all of which a
lso express TrkA. In summary, the study of neurotrophin receptor expre
ssion and function in neuroblastomas may provide important insights in
to the role that these pathways play in the pathogenesis and clinical
behavior of this tumor. Ultimately, these pathways may provide attract
ive targets for the development of therapy aimed at inducing different
iation or programmed cell death in these tumors.